サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1726160

ドラッグデリバリーの市場規模、シェア、動向分析レポート：製品別、用途別、最終用途別、地域別、セグメント別予測、2025年～2030年

Drug Delivery Devices Market Size, Share & Trends Analysis Report By Product, By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 170 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.28円
ドラッグデリバリーの市場規模、シェア、動向分析レポート：製品別、用途別、最終用途別、地域別、セグメント別予測、2025年～2030年
出版日: 2025年04月07日
発行: Grand View Research
ページ情報: 英文 170 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ドラッグデリバリー市場の成長と動向

Grand View Research, Inc.の最新レポートによると、ドラッグデリバリーデバイスの世界市場規模は、2025～2030年にかけて7.5%のCAGRを記録し、2030年までに6,674億米ドルに達する見込みです。

がん、神経疾患、糖尿病、その他の感染症の有病率の増加が、今後数年間におけるドラッグデリバリーデバイスの採用を促進すると予想されています。また、眼科、神経学、腫瘍学など様々な用途向けの製品発売の増加も市場成長を促進すると見られています。また、在宅医療現場での使用を目的としたウェアラブル薬剤送達デバイスの採用拡大も、市場を牽引すると予想されます。

ハイドロゲルは著名なドラッグデリバリービークルの一つであり、超分子ハイドロゲル、DNAハイドロゲル、バイオインスパイアードハイドロゲル、多機能ハイドロゲル、刺激応答性ハイドロゲルなどが含まれます。これらの先進的ハイドロゲルは、眼科、経口、腸、心疾患、がんなど様々な用途に使用されています。同様に、リポソーム、ナノ粒子、ミセルなどの他のビヒクルも様々な用途向けに開発されています。

市場に存在する主要参入企業は、様々な用途のドラッグデリバリーデバイスを開発・改良するために、M&A、提携、共同開発など様々な戦略を採用しています。さらに、エンドユーザーも企業とパートナーシップを結び、トレーニング目的や調査研究のためにドラッグデリバリーデバイスを入手しています。さらに、市場参入企業は、自社製品のリーチを拡大するために販売契約を結んでいます。したがって、各社による提携は予測期間中の市場成長を促進すると予想されます。

ドラッグデリバリー市場レポートハイライト

  • 吸入器セグメントは、喘息治療の需要に牽引され、2024年には23.9%のシェアで市場をリードします。しかし、従来型定量吸入器は温室効果ガス排出に大きく寄与しています。
  • 糖尿病向けドラッグデリバリーデバイス部門は、2024年に21.1%のシェアで市場を独占しました。
  • 2024年の市場シェアは、病院セグメントが29.0％で最大を占め、外科的介入や予防処置の需要増に牽引されました。
  • 北米のドラッグデリバリーデバイス市場は世界市場全体を支配し、2024年の売上高シェアは32.4%でした。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 ドラッグデリバリーデバイス市場の変数、動向、範囲

  • 市場系統の展望
    • 親市場の展望
    • 関連/付随市場の展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • ドラッグデリバリーデバイス市場分析ツール
    • 産業分析-ポーターのファイブフォース分析
    • PESTEL分析

第4章 ドラッグデリバリーデバイス市場：製品別、推定・動向分析

  • セグメントダッシュボード
  • ドラッグデリバリーデバイス市場：製品変動分析
  • ドラッグデリバリーデバイス市場：製品別展望
  • 2018～2030年の市場規模と予測と動向分析
  • 吸入器
  • 注射装置
  • インプラント
  • 局所送達システム
  • 経口投与システム
  • 眼科用送達システム
  • ネブライザー
  • 経皮パッチ
  • 輸液ポンプ

第5章 ドラッグデリバリーデバイス市場：用途別、推定・動向分析

  • セグメントダッシュボード
  • ドラッグデリバリーデバイス市場：用途変動分析
  • ドラッグデリバリーデバイス市場：用途別展望
  • 2018～2030年の市場規模と予測と動向分析
  • 腫瘍学
  • 感染症
  • 呼吸器疾患
  • 糖尿病
  • 心血管疾患
  • 自己免疫疾患
  • 中枢神経系疾患
  • その他

第6章 ドラッグデリバリーデバイス市場：最終用途別、推定・動向分析

  • セグメントダッシュボード
  • ドラッグデリバリーデバイス市場：最終用途変動分析
  • ドラッグデリバリーデバイス市場：最終用途別展望
  • 2018～2030年の市場規模と予測と動向分析
  • 病院
  • 診断センター
  • 外来手術センター/クリニック
  • 在宅ケア
  • その他

第7章 ドラッグデリバリーデバイス市場：地域別、推定・動向分析

  • 地域ダッシュボード
  • 地域別ドラッグデリバリーデバイス市場変動分析
  • ドラッグデリバリーデバイス市場：流通チャネルと最終用途による地域推定・動向分析
  • 2018～2030年の市場規模と予測と動向分析
  • 北米
    • 米国
    • カナダ
    • メキシコ
    • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • 韓国
    • オーストラリア
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 市場参入企業の分類
  • 主要企業プロファイル
    • Gerresheimer AG
    • WL Gore & Associates, Inc.
    • Abbott
    • Terumo Medical Corporation
    • Stryker
    • Medtronic
    • Boston Scientific Corporation
    • Novartis AG
    • Becton, Dickinson and Company
    • Teleflex Incorporated
図表

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. North America drug delivery devices market, by country, 2018 - 2030 (USD Billion)
  • Table 4. North America drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 5. North America drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 6. North America drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 7. U.S. drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 8. U.S. drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 9. U.S. drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 10. Canada drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 11. Canada drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 12. Canada drug delivery devices market, by end-use, (USD Billion) 2018 - 2030
  • Table 13. Mexico drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 14. Mexico drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 15. Mexico drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 16. Europe drug delivery devices market, by region, 2018 - 2030 (USD Billion)
  • Table 17. Europe drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 18. Europe drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 19. Europe drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 20. Germany drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 21. Germany drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 22. Germany drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 23. U.K. drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 24. U.K. drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 25. U.K. drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 26. France drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 27. France drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 28. France drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 29. Italy drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 30. Italy drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 31. Italy drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 32. Spain drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 33. Spain drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 34. Spain drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 35. Denmark drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 36. Denmark drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 37. Denmark drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 38. Sweden drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 39. Sweden drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 40. Sweden drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 41. Norway drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 42. Norway drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 43. Norway drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 44. APAC drug delivery devices market, by region, 2018 - 2030 (USD Billion)
  • Table 45. APAC drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 46. APAC drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 47. APAC drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 48. China drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 49. China drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 50. China drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 51. Japan drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 52. Japan drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 53. Japan drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 54. India drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 55. India drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 56. India drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 57. Thailand drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 58. Thailand drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 59. Thailand drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 60. South Korea drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 61. South Korea drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 62. South Korea drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 63. Australia drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 64. Australia drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 65. Australia drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 66. Latin America drug delivery devices market, by region, 2018 - 2030 (USD Billion)
  • Table 67. Latin America drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 68. Latin America drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 69. Latin America drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 70. Brazil drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 71. Brazil drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 72. Brazil drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 73. Argentina drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 74. Argentina drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 75. Argentina drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 76. Middle East and Africa drug delivery devices market, by region, 2018 - 2030 (USD Billion)
  • Table 77. Middle East and Africa drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 78. Middle East and Africa drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 79. Middle East and Africa drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 80. South Africa drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 81. South Africa drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 82. South Africa drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 83. Saudi Arabia drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 84. Saudi Arabia drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 85. Saudi Arabia drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 86. UAE drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 87. UAE drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 88. UAE drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 89. Kuwait drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 90. Kuwait drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 91. Kuwait drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Drug delivery devices market segmentation
  • Fig. 7 Market driver analysis (Current & future impact)
  • Fig. 8 Market restraint analysis (Current & future impact)
  • Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 10 Porter's Five Forces Analysis
  • Fig. 11 Drug delivery devices market, Product outlook key takeaways (USD Billion)
  • Fig. 12 Drug delivery devices market Product movement analysis 2023 & 2030 (USD Billion)
  • Fig. 13 Inhalers market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 14 Metered-dose inhalers (MDIs) market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 15 Dry powder inhalers (DPIs) market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 16 Others market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 17 Injection devices market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 18 Prefilled syringes market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 19 Auto-injectors market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 20 Pen injectors market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 21 Needle-free injectors market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 22 Wearable injectors market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 23 Implants market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 24 Contraceptive implants market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 25 Drug-eluting stents market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 26 Biodegradable implants market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 27 Topical delivery system market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 28 Creams market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 29 Gels market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 30 Ointments market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 31 Oral delivery system market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 32 Controlled-release tablets and capsules market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 33 Buccal and sublingual tablets market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 34 Occular delivery system market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 35 Nebulizers market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 36 Transdermal patches market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 37 Infusion pumps market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 38 Drug delivery devices market, application outlook key takeaways (USD Billion)
  • Fig. 39 Drug delivery devices market application movement analysis 2023 & 2030 (USD Billion)
  • Fig. 40 Oncology market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 41 Infectious diseases market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 42 Respiratory diseases market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 43 Diabetes market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 44 Cardiovascular diseases market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 45 Autoimmune diseases market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 46 Central nervous system disorders market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 47 Others market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 48 Drug delivery devices market, end use outlook key takeaways (USD Billion)
  • Fig. 49 Drug delivery devices market, end use movement analysis 2023 & 2030 (USD Billion)
  • Fig. 50 Hospitals market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 51 Diagnostic centers market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 52 Ambulatory surgery centers/clinics market, application outlook key takeaways (USD Billion)
  • Fig. 53 Home care settings market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 54 Others market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 55 Drug delivery devices market: Regional key takeaways (USD Billion)
  • Fig. 56 Drug delivery devices market regional outlook, 2023 & 2030 (USD Billion)
  • Fig. 57 North America drug delivery devices estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 58 US drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 59 Canada drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 60 Mexico drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 61 Europe drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 62 UK drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 63 Germany drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 64 France drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 65 Spain drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 66 Italy drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 67 Sweden drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 68 Norway drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 69 Denmark drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 70 Asia Pacific drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 71 China drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 72 Japan drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 73 India drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 74 South Korea drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 75 Australia drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 76 Thailand drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 77 Latin America drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 78 Brazil drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 79 Argentina drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 80 Middle East and Africa drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 81 South Africa drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 82 Saudi Arabia drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 83 UAE drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 84 Kuwait drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 85 List of key emerging company's/distribution channel disruptors/innovators
目次
Product Code: GVR-4-68038-435-2

Drug Delivery Devices Market Growth & Trends:

The global drug delivery devices market size is expected to reach USD 667.4 billion by 2030, registering a CAGR of 7.5% from 2025 to 2030, according to a new report by Grand View Research, Inc. Growing prevalence of cancer, neurological disorders, diabetes, and other infectious diseases is expected to drive the adoption of drug delivery devices in the coming years. In addition, increasing product launches for various applications such as ophthalmology, neurology, and oncology are also expected to propel the market growth. Growing adoption of wearable drug delivery devices for its usage in home-care settings is also expected to drive the market.

Hydrogel is one of the prominent drug delivery vehicles and includes supramolecular hydrogels, DNA hydrogels, bio-inspired hydrogels, multi-functional and stimuli-responsive hydrogels. These advanced hydrogels are used for various applications such as ophthalmic, oral, intestinal, cardiac illness, and cancer. Similarly, other vehicles such as liposomes, nanoparticles, and micelle are also being developed for various applications.

Key players present in the market are adopting various strategies such as mergers and acquisitions, partnership, and collaborations to develop and improve drug delivery devices for various applications. Moreover, end-users are also forming partnerships with companies to acquire drug delivery devices for training purpose and research studies. In addition, market players are also forming distribution agreement to expand the reach of their products. Therefore, alliances made by the players are expected to drive the market growth during the forecast period.

Drug Delivery Devices Market Report Highlights:

  • The inhalers segment leads the market with a share of 23.9% in 2024, driven by the demand for asthma treatment. However, conventional metered-dose inhalers contribute significantly to greenhouse gas emissions.
  • The drug delivery devices segment for diabetes dominated the market in 2024 with a share of 21.1%.
  • The hospitals segment held the largest market share in 2024 with a share of 29.0%, driven by the rising demand for surgical interventions and preventive procedures.
  • The North America drug delivery devices market dominated the overall global market and accounted for the 32.4% revenue share in 2024.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.21. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. End-use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. End use outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Drug Delivery Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing demand for novel drug delivery devices
      • 3.2.1.2. Increasing prevalence of chronic diseases
      • 3.2.1.3. Technological advancement in drug delivery devices
      • 3.2.1.4. Growing strategic alliances for drug delivery devices
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Challenges associated with various routes of drug delivery devices
  • 3.3. Drug Delivery Devices Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Drug Delivery Devices Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Drug Delivery Devices Market: Product Movement Analysis
  • 4.3. Drug Delivery Devices Market by Product Outlook (USD Billion)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. Inhalers
    • 4.5.1. Inhalers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.5.1.1. Metered-dose inhalers (MDIs)
        • 4.5.1.1.1. Metered-dose inhalers (MDIs) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.5.1.2. Dry powder inhalers (DPIs)
        • 4.5.1.2.1. Dry powder inhalers (DPIs) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.5.1.3. Others
        • 4.5.1.3.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.6. Injection Devices
    • 4.6.1. Injection Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.6.1.1. Prefilled Syringes
        • 4.6.1.1.1. Prefilled Syringes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.6.1.2. Auto-injectors
        • 4.6.1.2.1. Auto-injectors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.6.1.3. Pen Injectors
        • 4.6.1.3.1. Pen Injectors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.6.1.4. Needle-free Injectors
        • 4.6.1.4.1. Needle-free Injectors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.6.1.5. Wearable Injectors
        • 4.6.1.5.1. Wearable Injectors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.7. Implants
    • 4.7.1. Implants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.7.1.1. Contraceptive Implants
        • 4.7.1.1.1. Contraceptive Implants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.7.1.2. Drug-eluting Stents
        • 4.7.1.2.1. Drug-eluting Stents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.7.1.3. Biodegradable Implants
        • 4.7.1.3.1. Biodegradable Implants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.8. Topical Delivery System
    • 4.8.1. Topical Delivery System Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.8.1.1. Creams
        • 4.8.1.1.1. Creams Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.8.1.2. Gels
        • 4.8.1.2.1. Gels Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.8.1.3. Ointments
        • 4.8.1.3.1. Ointments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.9. Oral Delivery System
    • 4.9.1. Oral Delivery System Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.9.1.1. Controlled-release Tablets and Capsules
        • 4.9.1.1.1. Controlled-release Tablets and Capsules Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.9.1.2. Buccal and Sublingual Tablets
        • 4.9.1.2.1. Buccal and Sublingual Tablets Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.10. Occular Delivery System
    • 4.10.1. Occular Delivery System Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.11. Nebulizers
    • 4.11.1. Nebulizers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.12. Transdermal Patches
    • 4.12.1. Transdermal Patches Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.13. Infusion Pumps
    • 4.13.1. Infusion Pumps Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 5. Drug Delivery Devices Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Drug Delivery Devices Market: Application Movement Analysis
  • 5.3. Drug Delivery Devices Market by Application Outlook (USD Billion)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Oncology
    • 5.5.1. Oncology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.6. Infectious Diseases
    • 5.6.1. Infectious Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.7. Respiratory Diseases
    • 5.7.1. Respiratory Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.8. Diabetes
    • 5.8.1. Diabetes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.9. Cardiovascular Diseases
    • 5.9.1. Cardiovascular Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.10. Autoimmune Diseases
    • 5.10.1. Autoimmune Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.11. Central Nervous System Disorders
    • 5.11.1. Central Nervous System Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.12. Others
    • 5.12.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 6. Drug Delivery Devices Market: End-use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Drug Delivery Devices Market: End-use Movement Analysis
  • 6.3. Drug Delivery Devices Market by End-use Outlook (USD Billion)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5. Hospitals
    • 6.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.6. Diagnostic Centers
    • 6.6.1. Diagnostic Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.7. Ambulatory Surgery Centers/Clinics
    • 6.7.1. Ambulatory Surgery Centers/Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.8. Home Care Settings
    • 6.8.1. Home Care Settings Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.9. Others
    • 6.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. Drug Delivery Devices Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Dashboard
  • 7.2. Regional Drug Delivery Devices Market Movement Analysis
  • 7.3. Drug Delivery Devices Market: Regional Estimates & Trend Analysis by Distribution Channel & End-use
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 7.5. North America
    • 7.5.1. North America Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.2. U.S.
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Reimbursement scenario
      • 7.5.2.5. U.S. Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.3. Canada
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Reimbursement scenario
      • 7.5.3.5. Canada Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.4. Mexico
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. Reimbursement scenario
      • 7.5.4.5. Mexico Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.5. Europe
    • 7.5.6. Europe Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.7. UK
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Reimbursement scenario
      • 7.5.7.5. UK Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.8. Germany
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Competitive Scenario
      • 7.5.8.3. Regulatory Framework
      • 7.5.8.4. Reimbursement scenario
      • 7.5.8.5. Germany Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.9. France
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Competitive Scenario
      • 7.5.9.3. Regulatory Framework
      • 7.5.9.4. Reimbursement scenario
      • 7.5.9.5. France Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.10. Italy
      • 7.5.10.1. Key Country Dynamics
      • 7.5.10.2. Competitive Scenario
      • 7.5.10.3. Regulatory Framework
      • 7.5.10.4. Reimbursement scenario
      • 7.5.10.5. Italy Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.11. Spain
      • 7.5.11.1. Key Country Dynamics
      • 7.5.11.2. Competitive Scenario
      • 7.5.11.3. Regulatory Framework
      • 7.5.11.4. Reimbursement scenario
      • 7.5.11.5. Spain Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.12. Denmark
      • 7.5.12.1. Key Country Dynamics
      • 7.5.12.2. Competitive Scenario
      • 7.5.12.3. Regulatory Framework
      • 7.5.12.4. Reimbursement scenario
      • 7.5.12.5. Denmark Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.13. Sweden
      • 7.5.13.1. Key Country Dynamics
      • 7.5.13.2. Competitive Scenario
      • 7.5.13.3. Regulatory Framework
      • 7.5.13.4. Reimbursement scenario
      • 7.5.13.5. Sweden Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.14. Norway
      • 7.5.14.1. Key Country Dynamics
      • 7.5.14.2. Competitive Scenario
      • 7.5.14.3. Regulatory Framework
      • 7.5.14.4. Reimbursement scenario
      • 7.5.14.5. Norway Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Reimbursement scenario
      • 7.6.2.5. Japan Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Reimbursement scenario
      • 7.6.3.5. China Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Reimbursement scenario
      • 7.6.4.5. India Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.6.5. South Korea
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Reimbursement scenario
      • 7.6.5.5. South Korea Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.6.6. Australia
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Competitive Scenario
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. Reimbursement scenario
      • 7.6.6.5. Australia Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Competitive Scenario
      • 7.6.7.3. Regulatory Framework
      • 7.6.7.4. Reimbursement scenario
      • 7.6.7.5. Thailand Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.7. Latin America
    • 7.7.1. Latin America Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. Reimbursement scenario
      • 7.7.2.5. Brazil Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Reimbursement scenario
      • 7.7.3.5. Argentina Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.8. Middle East & Africa
    • 7.8.1. Middle East & Africa Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. Reimbursement scenario
      • 7.8.2.5. South Africa Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. Reimbursement scenario
      • 7.8.3.5. Saudi Arabia Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Competitive Scenario
      • 7.8.4.3. Regulatory Framework
      • 7.8.4.4. Reimbursement scenario
      • 7.8.4.5. UAE Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Competitive Scenario
      • 7.8.5.3. Regulatory Framework
      • 7.8.5.4. Reimbursement scenario
      • 7.8.5.5. Kuwait Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Key Company Profiles
    • 8.2.1. Gerresheimer AG
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. W. L. Gore & Associates, Inc.
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. Abbott
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Terumo Medical Corporation
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Stryker
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. Medtronic
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. Boston Scientific Corporation
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. Novartis AG
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. Becton, Dickinson and Company
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives
    • 8.2.10. Teleflex Incorporated
      • 8.2.10.1. Company overview
      • 8.2.10.2. Financial performance
      • 8.2.10.3. Product benchmarking
      • 8.2.10.4. Strategic initiatives